Amplicon Biosciences Private Limited
Founded in 2003 and headquartered in Maharashtra, India.
2003 | Thane, Maharashtra (India) | Active
Amplicon Biosciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 21 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 3.65%
- Profit Growth 201.07%
- Ebitda -15.33%
- Net Worth 32.20%
- Total Assets -21.91%
About Amplicon Biosciences
Amplicon Biosciences Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 April 2003 and has a history of 21 years and ten months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Swapan Deb and Suranjana Choudhury serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85195MH2003PTC140178
- Company No.
140178
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Apr 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Healthcare
Who are the key members and board of directors at Amplicon Biosciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swapan Deb  | Director | 28-Apr-2003 | Current |
| Suranjana Choudhury | Director | 28-Apr-2003 | Current |
Financial Performance of Amplicon Biosciences.
Amplicon Biosciences Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 3.65% increase. The company also saw a substantial improvement in profitability, with a 201.07% increase in profit. The company's net worth Soared by an impressive increase of 32.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amplicon Biosciences?
In 2017, Amplicon Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Amplicon Biosciences?
Unlock and access historical data on people associated with Amplicon Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amplicon Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amplicon Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.